129 related articles for article (PubMed ID: 711553)
1. Lysozyme levels and macrophage content of tumor tissue in C3H mice bearing fibrosarcoma transplants treated by radiation and Corynebacterium parvum.
Mendiondo O; Suit H; Fixler H
Int J Radiat Oncol Biol Phys; 1978; 4(9-10):829-34. PubMed ID: 711553
[No Abstract] [Full Text] [Related]
2. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice.
Gebhardt MC; Fisher B
J Natl Cancer Inst; 1979 Apr; 62(4):1035-41. PubMed ID: 285276
[No Abstract] [Full Text] [Related]
3. Modification of radiation responses of murine tumors by misonidazole (Ro 07-0582), host immune capability, and Corynebacterium parvum.
Stone HB; Milas L
J Natl Cancer Inst; 1978 Apr; 60(4):887-93. PubMed ID: 633396
[TBL] [Abstract][Full Text] [Related]
4. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
[No Abstract] [Full Text] [Related]
5. Combined radiotherapy and Corynebacterium parvum treatment of rat tumors with different immunogenicity.
Moroson H; Stowe S; Rotman M; Schechter M
Int J Radiat Oncol Biol Phys; 1978; 4(7-8):649-55. PubMed ID: 711536
[No Abstract] [Full Text] [Related]
6. Effect of Corynebacterium parvum and chronic Toxoplasma infection on metastatic brain tumors in mice.
Conley FK
J Natl Cancer Inst; 1979 Nov; 63(5):1237-44. PubMed ID: 291750
[No Abstract] [Full Text] [Related]
7. Efficacy of Corynebacterium parvum treatment of mice with sarcoma growing in normal or irradiated tissue.
Suit HD; Sedlacek R; Echteler S
Cancer Res; 1977 Nov; 37(11):4233-4. PubMed ID: 908052
[No Abstract] [Full Text] [Related]
8. Radiation-induced osteogenic sarcoma of C3H mouse: effects of Corynebacterium parvum and WBI on its natural history and response to irradiation.
Choi CH; Sedlacek RS; Suit HD
Eur J Cancer (1965); 1979 Apr; 15(4):433-42. PubMed ID: 285860
[No Abstract] [Full Text] [Related]
9. The effect of C. parvum therapy on intratumoral macrophage subpopulations.
McBride WH; Moore K
Adv Exp Med Biol; 1982; 155():731-6. PubMed ID: 7158508
[No Abstract] [Full Text] [Related]
10. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice.
Fisher B; Gunduz N
J Natl Cancer Inst; 1979 Jun; 62(6):1545-51. PubMed ID: 286125
[No Abstract] [Full Text] [Related]
11. Simple estimation of macrophage activity in tumour-bearing animals treated with Corynebacterium parvum.
Wilson RG
Br J Exp Pathol; 1981 Aug; 62(4):347-9. PubMed ID: 7295527
[TBL] [Abstract][Full Text] [Related]
12. Serum lysozyme as a marker of host resistance. I. Production by macrophages resident in rat sarcomata.
Currie GA; Eccles SA
Br J Cancer; 1976 Jan; 33(1):51-9. PubMed ID: 766806
[TBL] [Abstract][Full Text] [Related]
13. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide--VIII.
Fisher B; Gebhardt MC; Saffer EA
Int J Radiat Oncol Biol Phys; 1978; 4(11-12):975-82. PubMed ID: 721660
[No Abstract] [Full Text] [Related]
14. Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma.
Stone HB; Peters LJ; Milas L
J Natl Cancer Inst; 1979 Nov; 63(5):1229-35. PubMed ID: 291749
[No Abstract] [Full Text] [Related]
15. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism.
Fisher B; Wolmark N; Rubin H
J Natl Cancer Inst; 1976 Jul; 57(1):225-6. PubMed ID: 1003505
[TBL] [Abstract][Full Text] [Related]
16. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.
Woodruff MF; Dunbar N
Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
Moore K; McBride WH
Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
[TBL] [Abstract][Full Text] [Related]
18. [Antitumoral activity of various doses of corynebacterium parvum as a function of the age of mice].
Stiffel C; Chalvet H; Mazurek C
Ann Inst Pasteur Immunol (1985); 1985; 136D(1):19-27. PubMed ID: 3840664
[TBL] [Abstract][Full Text] [Related]
19. Active experimental inhibition of cancer by corynebacterium parvum.
Wrba H; Dutter A
Osterr Z Onkol; 1977 Oct; 4(2-3):60-1. PubMed ID: 579449
[TBL] [Abstract][Full Text] [Related]
20. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
Milas L; Gutterman JU; Basic I; Hunter N; Mavligit GM; Hersh EM; Withers HR
Int J Cancer; 1974 Oct; 14(4):493-503. PubMed ID: 4459276
[No Abstract] [Full Text] [Related]
[Next] [New Search]
